Search

Your search keyword '"de la Hoya, Miguel"' showing total 325 results

Search Constraints

Start Over You searched for: Author "de la Hoya, Miguel" Remove constraint Author: "de la Hoya, Miguel" Language english Remove constraint Language: english
325 results on '"de la Hoya, Miguel"'

Search Results

1. Specifications of the ACMG/AMP variant curation guidelines for the analysis of germline ATM sequence variants

2. Evidence-based recommendations for gene-specific ACMG/AMP variant classification from the ClinGen ENIGMA BRCA1 and BRCA2 Variant Curation Expert Panel

3. Associations of height, body mass index, and weight gain with breast cancer risk in carriers of a pathogenic variant in BRCA1 or BRCA2: the BRCA1 and BRCA2 Cohort Consortium

4. A New Set of in Silico Tools to Support the Interpretation of ATM Missense Variants Using Graphical Analysis

5. Polygenic risk modeling for prediction of epithelial ovarian cancer risk

6. Breast cancer risks associated with missense variants in breast cancer susceptibility genes

7. Copy number variants as modifiers of breast cancer risk for BRCA1/BRCA2 pathogenic variant carriers

8. Polygenic risk scores and breast and epithelial ovarian cancer risks for carriers of BRCA1 and BRCA2 pathogenic variants

9. Correction: Polygenic risk modeling for prediction of epithelial ovarian cancer risk

10. Comprehensive splicing analysis of the alternatively spliced CHEK2 exons 8 and 10 reveals three enhancer/silencer‐rich regions and 38 spliceogenic variants.

12. No clinical utility of KRAS variant rs61764370 for ovarian or breast cancer

14. Contribution of New Adenomatous Polyposis Predisposition Genes in an Unexplained Attenuated Spanish Cohort by Multigene Panel Testing

15. Genome-wide association and transcriptome studies identify target genes and risk loci for breast cancer

16. Ovarian cancer pathology characteristics as predictors of variant pathogenicity in BRCA1 and BRCA2

18. Association of breast cancer risk in BRCA1 and BRCA2 mutation carriers with genetic variants showing differential allelic expression: identification of a modifier of breast cancer risk at locus 11q22.3

19. P076: The ClinGen ENIGMA BRCA1/2 expert panel: A dynamic framework for evidence-based recommendations to improve classification criteria for variants in BRCA1/2*

20. P061: ATM and PALB2 variant curation guidelines progress update: ClinGen Hereditary Breast, Ovarian, and Pancreatic Cancer Variant Curation Expert Panel

21. BRCA1 and BRCA2 mutations in males with familial breast and ovarian cancer syndrome. Results of a Spanish multicenter study

23. Limited family structure and triple-negative breast cancer (TNBC) subtype as predictors of BRCA mutations in a genetic counseling cohort of early-onset sporadic breast cancers

25. Unexpected Findings in Hereditary Breast and Ovarian Cancer Syndrome: Low-Level Constitutional Mosaicism in BRCA2.

26. Association of Type and Location of BRCA1 and BRCA2 Mutations With Risk of Breast and Ovarian Cancer

27. A Large Case-Control Study Performed in Spanish Population Suggests That RECQL5 Is the Only RECQ Helicase Involved in Breast Cancer Susceptibility.

28. Splicing Analysis of 16 PALB2 ClinVar Variants by Minigene Assays: Identification of Six Likely Pathogenic Variants.

29. Minigene‐based splicing analysis and ACMG/AMP‐based tentative classification of 56 ATM variants.

32. Characterization of four novel BRCA2 large genomic rearrangements in Spanish breast/ovarian cancer families: review of the literature, and reevaluation of the genetic mechanisms involved in their origin

34. Detection of a large rearrangement in PALB2 in Spanish breast cancer families with male breast cancer

35. Evidence for a link between TNFRSF11A and risk of breast cancer

37. International distribution and age estimation of the Portuguese BRCA2 c.156_157insAlu founder mutation

39. Parity and the risk of breast and ovarian cancer in BRCA1 and BRCA2 mutation carriers

40. Comprehensive annotation of splice junctions supports pervasive alternative splicing at the BRCA1 locus: a report from the ENIGMA consortium

41. About 1% of the breast and ovarian Spanish families testing negative for BRCA1 and BRCA2 are carriers of RAD51D pathogenic variants

44. Genome-wide linkage scan reveals three putative breast-cancer-susceptibility loci

46. Minigene Splicing Assays Identify 20 Spliceogenic Variants of the Breast/Ovarian Cancer Susceptibility Gene RAD51C.

47. Evaluation of Rare Variants in the New Fanconi Anemia Gene ERCC4 (FANCQ) as Familial Breast/Ovarian Cancer Susceptibility Alleles

49. Transcriptome‐wide association study of breast cancer risk by estrogen‐receptor status

50. Characterization of the cancer spectrum in men with germline BRCA1 and BRCA2 pathogenic variants

Catalog

Books, media, physical & digital resources